Health Condition 1: H712- Cholesteatoma of mastoid
Conditions
Interventions
Intervention1: DEXMEDETOMIDINE INFUSION: After receiving the patients in the operating room, an intravenous line will be established with an 18 G intravenous cannula and infusion of lactated ringerâ??
Sponsors
Institute of Post Graduate Medical Education and Research
Eligibility
Inclusion criteria
Inclusion criteria: Randomly selected patients admitted in ENT ward with middle ear pathology belonging to ASA ( American Society of Anesthesiologist) status l or ll and aged from 18 to 60 years of either sex and willing to give consent will be included in the study
Exclusion criteria
Exclusion criteria: Pregnant and breast feeding women Pre-existing cardiac disease ,renal disorder ,hepatic disease and psychiatric disorder Patients refuses to participate. History suggestive of any coagulation disorder H/O Allergy to Drugs History suggestive of operation in same ear Any other contraindications for using labetalol and dexmedetomidine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dexmedetomidine and labetalol infusion both will be effective to induce controlled hypotension in patients undergoing middle ear surgery. However which drug will be more efficient in compare to other to improve bleeding and surgeons satisfaction and lower side effects and provide better surgical field condition will be evaluated.Timepoint: 20/03/2019 to 20/09/2019 | — |
Secondary
| Measure | Time frame |
|---|---|
| which drug will be more efficient in compare to other to improve bleeding,surgeons satisfaction, lower side effects, and provide better surgical field condition will be evaluated.Timepoint: 20/03/2019 to 20/09/2019 | — |
Countries
India
Contacts
Public ContactDr Purnendu Bikash Pramanik
Institute of Post Graduate Medical Education and Research Institute
Outcome results
None listed